Search Within

Andrew D Zelenetz

  1. "Stephen Nimer"
Formats
  1. Meeting Abstract (22)
  2. Journal Article (18)
Groups
  1. Center for Hematologic Malignancies (40)
  2. Department of Medicine (40)
  3. Hematologic Malignancies, Division of (40)
  4. Lymphoma (40)
  5. Radiation Oncology, Department of (26)
  6. Survivorship Research (26)

More Groups

People
  1. Stephen Nimer (40)
  2. Craig Moskowitz (38)
  3. Joachim Yahalom (26)
  4. Tarun Kewalramani (23)
  5. Carol Portlock (16)
  6. David Straus (14)

More People

Years
  1. 2012 (1)
  2. 2010 (1)
  3. 2008 (2)
  4. 2007 (2)
  5. 2006 (1)
  6. 2005 (4)

More Years

Publications
  1. Blood (28)
  2. British Journal of Haematology (3)
  3. Annals of Oncology (2)
  4. Bone Marrow Transplantation (2)
  5. Journal of Clinical Oncology (2)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Hematology (28)
  2. John Wiley & Sons (3)
  3. American Society of Clinical Oncology (2)
  4. Nature Publishing Group (2)
  5. Oxford University Press (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (40)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Normalization of pre-ASCT, FDG-PET imaging with second-line, non-cross-resistant, chemotherapy programs improves event-free survival in patients with Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Matasar, M. J.; Zelenetz, A. D.; Nimer, S. D.; Gerecitano, J.; Hamlin, P.; Horwitz, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging: Research paper
    Journal Article

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Zhang, Z.; Filippa, D.; Teruya-Feldstein, J.; Kewalramani, T.; Moskowitz, A. J.; Rice, R.; Maragulia, J.; more...
    British Journal of Haematology (2010)

    Fulltext@MSK | Save
  • Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Pre-transplant evaluation with both CT and PET following second-line therapy is essential for predicting outcome in patients with transplant-eligible relapsed and primary refractory Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Nimer, S. D.; Zelenetz, A. D.; Kewalramani, T.; Vanak, J. M.; Maragulia, J. C.; Yahalom, J.; Moskowitz, C.
    Blood (2008)

    Fulltext@MSK | Save
  • Late relapses characterize autologous transplantation (ASCT) in first complete remission (CR) for peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Kewalramani, T.; Horwitz, S.; Zelenetz, A. D.; Nimer, S. D.; Moskowitz, C. H.
    Blood (2007)

    Fulltext@MSK | Save
  • Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma
    Journal Article

    Moskowitz, C. H.; Hamlin, P. A.; Gabrilove, J.; Bertino, J. R.; Portlock, C. S.; Straus, D. J.; Gencarelli, A. N.; Nimer, S. D.; Zelenetz, A. D.
    Annals of Oncology (2007)

    Fulltext@MSK | Save
  • Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma
    Journal Article

    Kewalramani, T.; Zelenetz, A. D.; Teruya-Feldstein, J.; Hamlin, P.; Yahalom, J.; Horwitz, S.; Nimer, S. D.; Moskowitz, C. H.
    British Journal of Haematology (2006)

    Fulltext@MSK | Save
  • Second-line therapy with ICE followed by high dose therapy and autologous stem cell transplantation for relapsed/refractory peripheral T-Cell lymphomas: Minimal benefit when analyzed by intent to treat
    Meeting Abstract

    Horwitz, S.; Moskowitz, C.; Kewalramani, T.; Hamlin, P.; Straus, D.; O'connor, O.; Noy, A.; Portlock, C.; Nimer, S.; Palomba, M. L.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL
    Journal Article

    Moskowitz, C. H.; Zelenetz, A. D.; Kewalramani, T.; Hamlin, P.; Lessac-Chenen, S.; Houldsworth, J.; Olshen, A.; Chaganti, R.; Nimer, S.; Teruya-Feldstein, J.
    Blood (2005)

    Fulltext@MSK | Save
  • High dose chemoradiotherapy and ASCT can overcome the prognostic importance of bcl-2, bim, and p53 in relapsed/refractory Hodgkin's lymphoma
    Meeting Abstract

    Persky, Daniel; Teruya-Feldstein, Julie; Kewalramani, Tarun; Bonner, Pauline D; Iasonos, Alexia; Rice, David; Yahalom, Joachim; Nimer, Stephen D; Zelenetz, Andrew D; Moskowitz, Craig H.
    Blood (2005)

    Fulltext@MSK | Save